Metformin Is Associated with Reduced Tissue Factor Procoagulant Activity in Patients with Poorly Controlled Diabetes.

Marco WitkowskiJulian FriebelTermeh TabaraieSinah GrabitzAndrea DörnerLena TaghipourKai JakobsBernd StratmannDiethelm TschoepeUlf LandmesserUrsula Rauch

Published in: Cardiovascular drugs and therapy (2020)

Our data are the first to report that metformin is associated with reduced plasma TF procoagulant activity possibly explaining-at least in part-the vasculoprotective properties of metformin.

Keyphrases

type diabetes
cardiovascular disease
glycemic control
big data
metabolic syndrome
skeletal muscle
insulin resistance